Publications

May 2017
Supplement

Battle for the Soul of Capitalism: Unilever and the Kraft Heinz Takeover Bid (B)

By: William W. George and Amram Migdal

This (B) case describes the aftermath of Unilever’s February 2017 rejection of Kraft Heinz Company’s (KHC)/3G Capital’s (3G) unsolicited $143 billion takeover offer. In an effort to defend itself against future attempts by KHC/3G or other suitors, Unilever announced on... View Details

Keywords: Value Creation; Restructuring; Performance Improvement

1997
Book

Environment, Ethics, and Behavior: The Psychology of Environmental Valuation and Degradation

By: M. H. Bazerman, D. M. Messick, A. E. Tenbrunsel and K. A. Wade-Benzoni

Keywords: Ethics; Environmental Sustainability; Valuation

Find at Harvard

15 May 2017
Sharpening Your Skills

The Promises and Limitations of Big Data

discusses the water industry as an example, and the organizational changes and levers relevant to extracting value from emerging data-analytics technologies. Big Data: Big Deal... View Details

Keywords: by Sean Silverthorne; Financial Services; Utilities; Public Administration; Health

Article

Breakthroughs and the 'Long Tail' of Innovation

The largely erroneous perception that breakthroughs are impossible to predict arises from the tendency to focus on just the breakthroughs while ignoring the iterative process of invention and its distribution of outcomes. When all inventions are considered, they... View Details

Keywords: Diversity; Collaborative Innovation and Invention; Independent Innovation and Invention; Innovation and Management; Business Processes; Performance Capacity; Performance Improvement

Find at Harvard

Read Now

January 4, 2019
Article

How Companies Can Balance Social Impact and Financial Goals

By: Marya L. Besharov, Wendy K. Smith and Michael Tushman

It’s notoriously difficult for a business to manage two separate-but-equal goals—making money and creating social value at the same time, for example, or managing an existing business at the same time that you invent a new one. Most attempts at managing these... View Details

Keywords: Goals and Objectives; Management; Corporate Social Responsibility and Impact; Profit; Decision Making

Register to Read

August 2005 (Revised December 2006)
Case

Procter & Gamble: Electronic Data Capture and Clinical Trial Management

By: Robert S. Huckman and Mark J. Cotteleer

Considers whether the management of Procter & Gamble (P&G) Pharmaceuticals should adopt Web-based electronic data capture (EDC) as the default standard for the management of its clinical drug trials. Provides a detailed description of the existing paper-based process... View Details

Keywords: Health Testing and Trials; Internet and the Web; Information Technology; Adoption; Business Processes; Industry Structures; Technological Innovation; Service Operations; Pharmaceutical Industry; United States

05 Dec 2014
Working Paper Summaries

Seesaws and Social Security Benefits Indexing

Keywords: by Matthew Weinzierl

01 Jun 2008
News

Greed, Gullibility, and Optimism

reestablish equilibrium. And until equilibrium is reestablished, there is little prospect of stable or modestly increasing prices. Is the future as bleak as it sounds? There’s always hope. Markets do correct, eventually. There will always... View Details

Keywords: Deborah Blagg; Finance; Management; Real Estate

16 Mar 2023
Blog Post

HySynergy and Crossbridge Energy

In January 2023, Professors Willy Shih and Mike Toffel led more than 40 HBS MBA students on site visits to witness the energy transition and innovative sustainable production activities throughout Denmark... View Details

December 2014 (Revised October 2017)
Case

Social Business at Novartis: Arogya Parivar

By: Michael E. Porter, Mark R. Kramer and David Lane

Late in 2013, Novartis CEO Joseph Jimenez was considering whether or how to deepen the company's investment in Arogya Parivar, its profitable program that sold Novartis medicines in rural India while expanding access to medicine and health information to millions of... View Details

Keywords: Shared Value; India; Kenya; Vietnam; Novartis; Arogya Parivar; Social Business; Multinational Firms and Management; Competitive Advantage; Corporate Social Responsibility and Impact; Pharmaceutical Industry; Viet Nam; Kenya; India

March 2014 (Revised January 2015)
Case

Prodigy Network: Democratizing Real Estate Design and Financing

By: Karim R. Lakhani, Katja Hutter and Greta Friar

This case follows Rodrigo Nino, founder and CEO of commercial real estate development company Prodigy Network, as he develops an equity-based crowdfunding model for small investors to access commercial real estate in Colombia, then tries out the model in the U.S. U.S.... View Details

Web

Corporate Strategy - Institute For Strategy And Competitiveness

actions guarantees superior economic performance. Companies compete at the level of individual businesses, where strategic positioning within an industry creates value for customers. Successful strategy at the corporate level must produce... View Details

Article

Meaning and Momentum in the Integrated Reporting Movement

By: Robert G. Eccles, Michael P. Krzus and Sydney Ribot

In this summary of their recently published book, the authors provide an update of the state of the integrated reporting (or ) movement, whose aim is to persuade companies to provide fuller disclosure of material nonfinancial (or "ESG") factors and how they are... View Details

Keywords: Integrated Reporting; Integrated Corporate Reporting

Find at Harvard

Read Now

April 2019
Case

Afterpay U.S.: The Omnichannel Dilemma

By: Antonio Moreno, Donald Ngwe and George Gonzalez

In 2018, Nick Molnar, the founder of the Australia-based online payment service Afterpay began its expansion to the U.S. market. The service had gained a loyal following in Australia by enabling customers to pay for online purchases through four interest-free... View Details

June 2023 (Revised July 2024)
Case

Biogen and the Aduhelm Melee

By: Amitabh Chandra and Lauren Gunasti

Alzheimer's Disease is a devastating condition affecting millions of Americans. At this time, there is no cure. In 2021, Biogen's Aduhelm (aducanumab) received FDA approval under the accelerated approval pathway after a controversial approval process.

This... View Details

Keywords: Health Testing and Trials; Governing Rules, Regulations, and Reforms; Valuation; Product Development; Pharmaceutical Industry

January 2009 (Revised June 2014)
Case

CityCenter (A): Vision and Design

By: A. Eugene Kohn, John D. Macomber and Ben Creo

CityCenter is a $9 billion project for MGM MIRAGE. The project's star architects have a major disagreement about a critical design issue. Bill Smith, head of the MGM MIRAGE Design Group, must resolve this issue to the satisfaction of all the project's stakeholders.... View Details

Keywords: Buildings and Facilities; Cost vs Benefits; Design; Construction; Projects; Business and Stakeholder Relations; Conflict Management; Value Creation